What are the recommended birth control options for pediatric patients, including combined oral contraceptive pills for adolescents aged 12 years and older, progestin‑only pills for those younger than 12, and long‑acting reversible contraception?

Birth Control for Pediatric Patients

Long-acting reversible contraception (LARC), specifically the progestin implant and IUDs, should be considered first-line contraceptive choices for adolescents given their superior efficacy, safety, and ease of use. 1

Recommended Approach: Counsel Most Effective Methods First

When counseling adolescents about contraception, present options in order from most to least effective, starting with LARC methods 1:

First-Line: Long-Acting Reversible Contraception (LARC)

Progestin Implants (Implanon/Nexplanon)

• Efficacy: <0.05% failure rate with typical use—the most effective reversible method 1
• Duration: 3 years of protection
• Key advantages: No daily adherence required, ideal for adolescents who struggle with compliance
• Common side effect: Unpredictable bleeding or spotting (main reason for discontinuation)
• Important: Safe for nulliparous adolescents, can be placed immediately postpartum 1

Intrauterine Devices (IUDs)

• Efficacy: 0.2-0.8% failure rate depending on type 1
• Options available:
  • Levonorgestrel IUD (52 mg): 5 years, 0.2% failure rate
  • Levonorgestrel IUD (13.5 mg): 3 years
  • Copper IUD: 10 years, 0.8% failure rate (also serves as emergency contraception within 5 days)
• Critical point: Safe for nulliparous adolescents—past concerns about infertility are unfounded 1
• STI screening: Can be performed on day of insertion; treatment can occur with IUD in place if needed 1
• Contraindications are limited: Current purulent cervicitis, active gonorrhea/chlamydia, or current PID—past PID is NOT a contraindication 1

Second-Line: Short-Acting Hormonal Methods

Combined Oral Contraceptive Pills (COCs)

• Efficacy: 9% failure rate with typical use 1
• Starting recommendation: Begin with 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate 1
• No pelvic exam required: Can prescribe based on medical history and blood pressure alone 1
• Same-day "quick start": Initiate at the visit if reasonably certain patient is not pregnant
• Backup contraception: Use condoms or abstinence for first 7 days if started >5 days after menstrual bleeding began 2
• Prescribing: Provide up to 1 year supply at once 1
• Non-contraceptive benefits: Excellent for acne, dysmenorrhea, heavy menstrual bleeding 1

Important contraindications for COCs 1:

• Severe uncontrolled hypertension (≥160/100 mmHg)
• Migraines with aura
• Current thromboembolism or thrombophilia
• Active liver disease
• Complicated diabetes with vascular disease

Note on smoking: NOT a contraindication in adolescents and adults <35 years 1

DMPA (Depo-Provera) Injection

• Efficacy: 6% failure rate with typical use 1
• Dosing: Every 13 weeks
• Advantages: Highly effective, much safer than pregnancy despite concerns about bone mineral density 1
• Side effects: Irregular bleeding initially (improves over time), potential weight gain, decreased bone mineral density (recovers after discontinuation) 1
• Bone health counseling: Recommend 1300 mg calcium and 600 IU vitamin D daily, plus weight-bearing exercise 1
• FDA black-box warning: Regarding BMD, but ACOG does not recommend limiting use to 2 years 1

Contraceptive Patch and Vaginal Ring

• Efficacy: 9% failure rate with typical use (same as COCs) 1
• Same principles as COCs: Similar risks, benefits, and contraindications
• Advantage: May improve adherence by eliminating daily pill-taking 3

Essential Concurrent Protection

Condoms must be encouraged for ALL sexually active adolescents regardless of other contraceptive method used 1—they are the only method that protects against STIs including HIV, gonorrhea, chlamydia, and HPV 3.

Age-Specific Considerations

The evidence does NOT support different contraceptive recommendations based on age <12 vs ≥12 years as suggested in the expanded question. The 2014 AAP guidelines make clear that all contraceptive methods discussed are appropriate for adolescents when medically indicated, without age-specific restrictions for combined vs progestin-only methods 1.

Critical Practice Points

No pelvic examination required 1: Prescribe contraceptives or refer for IUD placement without conducting a pelvic exam. STI screening can be performed via vaginal swab or urine.

Confidentiality is paramount 1: Adolescents should be seen alone, with assurance of confidentiality within state and federal law limits. This is essential for honest disclosure and adherence.

Same-day initiation 4: Best practice is providing the chosen contraceptive method on the same day as counseling. If not possible, offer bridging contraception and/or emergency contraception prescription.

Emergency contraception 3: Advance prescription should be part of routine adolescent care. Plan B One-Step (levonorgestrel 1.5 mg) is available over-the-counter for all ages. Ulipristal acetate may be more effective, especially in heavier women and at the end of the 5-day window.

Common Pitfalls to Avoid

1. Don't delay contraception for pelvic exam: This creates unnecessary barriers 1
2. Don't rely on abstinence counseling alone: While abstinence is 100% effective, adherence is low over time; provide comprehensive contraceptive access 1
3. Don't withhold DMPA due to bone density concerns: The method is much safer than pregnancy 1
4. Don't assume IUDs are inappropriate for nulliparous teens: This outdated belief prevents access to the most effective methods 1
5. Don't forget to counsel about condoms: Even with highly effective contraception, STI protection is essential 1

The 2025 AAP guidelines reinforce that health systems must support same-day LARC placement, telehealth contraceptive services, and confidential billing practices to optimize adolescent contraceptive access 4.